Results from Symplicity HTN-2

Summary

This article discusses the results of the first human randomized controlled trial of sympathetic renal denervation as a treatment for treatment-resistant hypertension, which showed substantial reductions in systolic blood pressure.

  • Renal Disease
  • Hypertension & Kidney Disease
  • Hypertensive Disease
  • Interventional Radiology Clinical Trials
View Full Text